Company Filing History:
Years Active: 2021-2025
Title: Apeng Liang: Innovator in Kinase Inhibitors
Introduction
Apeng Liang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors for the treatment of various diseases.
Latest Patents
Liang holds two patents that showcase his innovative work. His first patent involves "3-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseases." This compound can be utilized as a kinase inhibitor and serves as a potential drug for treating ROS1, NTRK, ALK, and other kinase-mediated diseases. His second patent focuses on a "Crystal form of deuterated AZD9291, preparation method therefor, and use thereof." This crystal form exhibits stable physical and chemical properties, improving therapeutic effects in cancer treatment.
Career Highlights
Apeng Liang is currently associated with Tyk Medicines Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments for complex diseases.
Collaborations
Liang collaborates with esteemed colleagues, including Yusheng Wu and Chengshan Niu, to further enhance the impact of his research.
Conclusion
Apeng Liang's innovative contributions to the field of medicinal chemistry highlight his dedication to improving healthcare through the development of effective treatments. His patents reflect a commitment to addressing critical medical challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.